Indication
Bone and Soft Tissue Sarcoma
1 clinical trial
2 products
Product
MitoxantroneClinical trial
A Multicenter, Open-label, Phase Ib Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma Who Has Failed At Least One Prior Line of TherapyStatus: Terminated, Estimated PCD: 2023-02-03